SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Pfizer Signs Licensing Agreement With Starna Therapeutics Worth Up to $2.63 Billion

Pfizer announced it entered into a licensing agreement with Starna Therapeutics valued at up to USD 2.63 billion.

PFE

Related stories